Shan Ahmed Khan

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

CSL share price rebounds as inflation cools; ASX:CSL turns to February results and RBA call

CSL share price rebounds as inflation cools; ASX:CSL turns to February results and RBA call

CSL Ltd shares closed up 1.0% at A$170.00 on Wednesday. The biotech heavyweight recovered some ground after sliding 2.4% in the prior session as Australian stocks steadied after a softer inflation reading. The stock traded between A$168.65 and A$170.52 and is down about 41% over the past year, hovering near its 52-week low of A$168.00. Investing.com Australia
Bitmine (BMNR) stock dips after company says crypto-and-cash holdings hit $14.2 billion

Bitmine (BMNR) stock dips after company says crypto-and-cash holdings hit $14.2 billion

Shares of Bitmine Immersion Technologies Inc fell 2.1% to $32.65 in afternoon trade on Tuesday, after swinging between $31.41 and $34.13 on volume of about 34 million shares. The company said it held $14.2 billion in crypto and cash, including 4.144 million ether — the token that powers the Ethereum network — and chairman Tom Lee said he was “excited about the prospects for Ethereum in 2026.” PR Newswire
Travere Therapeutics TVTX stock slides 5% as FDA decision on Filspari nears

Travere Therapeutics TVTX stock slides 5% as FDA decision on Filspari nears

Nasdaq-listed Travere Therapeutics shares fell 5.3% to $36.09 in afternoon trading on Tuesday as investors looked toward next week’s U.S. FDA decision deadline on expanding its kidney drug Filspari into focal segmental glomerulosclerosis. The FDA’s Prescription Drug User Fee Act, or PDUFA, target action date is Jan. 13, and the stock has ranged from $34.88 to $39.16 in the session. SEC
Dow nears 50,000 as Nvidia CES remarks ignite SanDisk, Micron surge and lift Wall Street

Dow nears 50,000 as Nvidia CES remarks ignite SanDisk, Micron surge and lift Wall Street

U.S. stocks rose on Tuesday, lifting the Dow to a fresh record as chip and healthcare shares led gains. At about 2:30 p.m. ET, the Dow was up 1.02% at 49,476.54, while the S&P 500 gained 0.62% to 6,944.55 and the Nasdaq rose 0.61% to 23,537.96. SanDisk jumped 23% and Moderna climbed 10%; Argent Capital portfolio manager Jed Ellerbroek said he expects “a very strong earnings season for Big Tech” and higher capex, short for capital spending. Reuters
Johnson Controls (JCI) stock slides after Nvidia’s CES cooling claim spooks data-center bulls

Johnson Controls (JCI) stock slides after Nvidia’s CES cooling claim spooks data-center bulls

Johnson Controls International fell 5.5% to $114.79 in afternoon trading on Tuesday after Nvidia CEO Jensen Huang said the chipmaker’s next-generation Vera Rubin platform could sharply reduce cooling needs in data centers and that “no water chillers are necessary for data centres.” The stock has traded between $108.41 and $120.39, and other heating, ventilation and air-conditioning names also weakened. Barclays analysts led by Julian Mitchell said investors “should not take their comments lightly” and estimated data centers account for a low-double-digit share of Johnson Controls’ sales. Reuters
1 316 317 318 319 320 610
AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 STRONG BUY

Xylem

NYSE: XYL 95 / 100
#2 BUY

AerCap

NYSE: AER 93 / 100
#3 BUY ON WEAKNESS

Visa

NYSE: V 90 / 100
#4 TACTICAL BUY

Chevron

NYSE: CVX 87 / 100
#5 ACCUMULATE

UPS

NYSE: UPS 84 / 100
View full portfolio
Editorial model selection. Not personalised advice.